The Clinical Efficacy of Multidose Oritavancin: A Systematic Review

• Main Authors: Giammarco Baiardi (Author), Michela Cameran Caviglia (Author), Fabio Piras (Author), Fabio Sacco (Author), Roberta Prinapori (Author), Maria Luisa Cristina (Author), Francesca Mattioli (Author), Marina Sartini (Author), Emanuele Pontali (Author)
• Format: Book
• Published: MDPI AG, 2023-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Oritavancin (ORI) is a semisynthetic lipoglycopeptide approved as a single 1200 mg dose intravenous infusion for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) caused by Gram-positive organisms in adults. The pharmacokinetic/pharmacodynamic (PK/PD) linear kinetic profi...